While brand-name weight loss drugs are in short supply, a market for alternatives thrives
High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the meantime, a market for cheaper, compounded drugs thrives.
GLP-1 hybrid drug being tested as weight-loss aid
The manufacturer of Ozempic is testing amycretin, an experimental weight-loss pill that appears to help people quickly shed pounds.
GLP-1 weight loss drugs being considered for Alzheimer's treatments
Bre Teamer chats with Dr. Alex Zayid of Icon Anti-Aging about recent developments and research that supports using Alzheimer's as a tool to treat Alzheimer's.
Noom to offer compounded GLP-1 drug to rival pricey branded weight loss meds
Noom is the latest digital health company to jump into the off-label weight loss drug market to make medications more accessible to consumers. | Noom is the latest digital health company to jump into the off-label weight loss drug market to make medications more accessible to consumers.
Exercising On Weight Loss Drugs May Have a Surprising Side Effect (Hint: It's Not Just More Weight Loss)
A recent study suggests that people taking the GLP-1 liraglutide experienced more bone loss than people who exercised during the same time period. However, the study also found that exercising while taking liraglutide and other GLP-s may help prevent bone loss.
The Price War in Weight-Loss Drugs Is Here
Novo Nordisk and Eli Lilly are offering discounts to encourage more insurance coverage of the medicines, which carry price tags of over $1,000 a month.
Scientists behind development of weight-loss drugs win award
Weight-loss drugs like Ozempic are booming in popularity, but experts warn they aren't silver bullets for obesity.
GLP-1 pills are coming, and they could revolutionize weight-loss treatment
At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...
Does ‘nature’s Ozempic’ really work? Trendy GLP-1 supplements are designed to supercharge weight loss for a fraction of the price
Why fork over thousands of dollars a month for prescription weight loss jabs when store-bought supplements claim to have the ...
This Small-Cap Stock Has a Promising GLP-1 Drug That Could Rival Novo Nordisk's and Eli Lilly's Weight Loss Treatments
In early-stage trials, oral weight-loss drugs from Eli Lilly and Novo Nordisk have shown that they can help patients achieve ...
Becker's Hospital Review3d
GLP-1 weight loss pills are in the works: What to know
GLP-1 weight loss medications like Ozempic and Wegovy have become blockbuster drugs, but the need for weekly injections has limited their use. This may soon change, as several oral versions ...
Futurism on MSN11h
Novo Nordisk's New Weight Loss Drug Shows Ominous Psychiatric Side Effects
Novo Nordisk, the manufacturer behind Ozempic and Wegovy, has another weight loss medication in the works with some ...
Digital health company Noom to offer compounded GLP-1 drug through new weight loss program
Digital health company Noom on Thursday announced it will offer a compounded GLP-1 drug as part of a new weight loss product ...
GLP-1 drugs could help prevent 34,000 heart attacks and strokes in the US each year, research suggests
Certain blockbuster weight-loss drugs have been found to protect the heart in significant ways, and new research suggests ...
Fast food giants are jumping into the Ozempic game with tiny protein pizzas for people on weight-loss drugs
The world's biggest food company is targeting Ozempic users with small, protein-packed meals for under $5.